From ASCO: Updates in HER2-positive breast cancers

Article

Debu Tripathy blog image

Debu Tripathy, MD, editor-in-chief of CURE, discusses preliminary studies on combining Herceptin (trastuzumab) with existing drugs to treat HER2-positive breast cancer. These highlighted studies were presented at the 2013 American Society of Clinical Oncology's annual meeting in Chicago.

Related Videos
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Image of a woman with black hair.